Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The **chromatin–histone complex** refers to the structural assembly found in eukaryotic cell nuclei where long strands of genomic DNA are packaged with proteins called histones. The basic repeating unit is the nucleosome, which consists of approximately 147 base pairs of DNA wrapped around an octamer composed of two each of four core histones: H2A, H2B, H3, and H4. Linker histones like H1 bind between nucleosomes for further stabilization and compaction. This organization allows efficient packaging within the nucleus while regulating access for processes such as transcription, replication, repair, and recombination. The dynamic nature of this structure is modulated by post-translational modifications on histones—including acetylation and methylation—which influence gene accessibility and activity. Aberrations in these processes contribute to various diseases including cancer through epigenetic misregulation[1][3][4][5].
Drugs act on chromatin indirectly by modifying histones—e.g., acetylation/deacetylation, methylation/demethylation—rather than binding to the whole chromatin–histone complex.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Chromatin–histone complex.